Dianthus Therapeutics Inc (DNTH)
24.29
-0.64
(-2.57%)
USD |
NASDAQ |
May 10, 16:00
24.36
+0.07
(+0.29%)
After-Hours: 20:00
Dianthus Therapeutics Price to Book Value: 4.221 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 10, 2024 | 4.221 |
| May 09, 2024 | 4.332 |
| May 08, 2024 | 4.138 |
| May 07, 2024 | 4.178 |
| May 06, 2024 | 4.157 |
| May 03, 2024 | 4.484 |
| May 02, 2024 | 4.172 |
| May 01, 2024 | 3.915 |
| April 30, 2024 | 3.710 |
| April 29, 2024 | 3.806 |
| April 26, 2024 | 3.736 |
| April 25, 2024 | 3.648 |
| April 24, 2024 | 3.705 |
| April 23, 2024 | 4.07 |
| April 22, 2024 | 4.039 |
| April 19, 2024 | 4.040 |
| April 18, 2024 | 4.106 |
| April 17, 2024 | 4.056 |
| April 16, 2024 | 4.195 |
| April 15, 2024 | 4.392 |
| April 12, 2024 | 4.499 |
| April 11, 2024 | 4.327 |
| April 10, 2024 | 3.966 |
| April 09, 2024 | 4.192 |
| April 08, 2024 | 4.098 |
| Date | Value |
|---|---|
| April 05, 2024 | 4.360 |
| April 04, 2024 | 4.298 |
| April 03, 2024 | 4.558 |
| April 02, 2024 | 4.638 |
| April 01, 2024 | 5.165 |
| March 28, 2024 | 5.214 |
| March 27, 2024 | 5.318 |
| March 26, 2024 | 5.478 |
| March 25, 2024 | 5.386 |
| March 22, 2024 | 5.551 |
| March 21, 2024 | 4.856 |
| March 20, 2024 | 4.710 |
| March 19, 2024 | 4.595 |
| March 18, 2024 | 4.579 |
| March 15, 2024 | 4.875 |
| March 14, 2024 | 4.670 |
| March 13, 2024 | 5.087 |
| March 12, 2024 | 4.366 |
| March 11, 2024 | 4.354 |
| March 08, 2024 | 4.363 |
| March 07, 2024 | 4.396 |
| March 06, 2024 | 4.339 |
| March 05, 2024 | 4.302 |
| March 04, 2024 | 4.420 |
| March 01, 2024 | 4.471 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.559
Minimum
Dec 18 2023
5.551
Maximum
Mar 22 2024
2.593
Average
2.932
Median
Price to Book Value Benchmarks
| Mersana Therapeutics Inc | 8.985 |
| Equillium Inc | 2.390 |
| Monopar Therapeutics Inc | 2.100 |
| Larimar Therapeutics Inc | 5.559 |
| Vera Therapeutics Inc | 22.13 |
Price to Book Value Related Metrics
| PS Ratio | 78.75 |
| Price | 24.29 |
| Earnings Yield | -23.47% |
| Market Cap | 712.83M |